Variability in perioperative evaluation and resource utilization in pediatric patients with suspected biliary

Sarah B Cairo1, Arturo Aranda2, Marisa Bartz-Kurycki3

  • 1Department of Pediatric Surgery, John R Oishei Children's Hospital, Buffalo, NY.

Insights

Pediatric biliary dyskinesia (BD) diagnosis and treatment show significant variability. Non-white race and psychiatric comorbidities increase the risk of persistent symptoms after gallbladder removal.

Area of Science:

  • Pediatric Surgery
  • Gastroenterology
  • Health Services Research

Background:

  • Biliary dyskinesia (BD) is a frequent reason for pediatric cholecystectomy.
  • Diagnosis relies on gallbladder ejection fraction (GB-EF), but pediatric work-up and management remain controversial.

Purpose of the Study:

  • To compare perioperative work-up and outcomes in children undergoing cholecystectomy for BD across multiple institutions.
  • To identify factors associated with persistent symptoms post-operatively.

Main Methods:

  • Multi-institutional retrospective review of 678 pediatric patients undergoing cholecystectomy for BD.
  • Analysis of patient demographics, pre-operative work-up, and post-operative outcomes.
  • Multivariate analysis to identify risk factors for persistent symptoms.

Main Results:

  • Significant variability observed in initial patient evaluation (pediatric surgeons, gastroenterologists, emergency department) and follow-up protocols across institutions (p < 0.001).
  • Gallbladder ejection fraction (EF < 15%) was reported in 44.8% of patients.
  • Post-operative symptoms persisted in 35.3% of patients; non-white race and psychiatric comorbidities were associated with increased risk.

Conclusions:

  • Substantial variability exists in the pre- and post-operative evaluation and management of pediatric BD.
  • Standardized data collection and prospective research are necessary to establish optimal care pathways for pediatric BD.
Abstract

Related Concept Videos

Multi-input and Multi-variable systems01:22

Multi-input and Multi-variable systems

Cruise control systems in cars are designed as multi-input systems to maintain a driver's desired speed while compensating for external disturbances such as changes in terrain. The block diagram for a cruise control system typically includes two main inputs: the desired speed set by the driver and any external disturbances, such as the incline of the road. By adjusting the engine throttle, the system maintains the vehicle's speed as close to the desired value as possible.
In the absence of...
411
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
225
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
285
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
212
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
271